Global Cerebral Palsy Market, By Type (Ataxia Cerebral Palsy, Athetoid Cerebral Palsy, Congenital Cerebral Palsy, Diplegia of Cerebral Palsy, Hemiparesis of Cerebral Palsy, Postnatal Cerebral Palsy, Spastic Cerebral Palsy and Others), Diagnosis (Imaging Tests, Laboratory Tests and Others), Treatment (Therapy, Medication and Surgery), Medical Devices (Orthotic Devices, ENT-Devices and Eye-Tracking Devices), Mobility Aids (Walkers, Walking Sticks and Canes, Crutches, Standers, Lifts, Wheelchairs, Power Scooters and Others), End User (Hospitals, Home Care, Physiotherapy Centres, Pathology Centres, Ambulatory, Speciality Clinics and Others) – Industry Trends and Forecast to 2030.
Cerebral Palsy Market Analysis and Size
Overall growth in the demand for cerebral palsy treatment, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of cerebral palsy market. Cerebral palsy is one of the most common motor disabilities in children, with a significant number of new cases being diagnosed each year. The rising incidence and prevalence of cerebral palsy drive the demand for diagnostic and treatment options, thereby fueling market growth. Overall, the cerebral palsy market is expected to grow due to increasing awareness, technological advancements, supportive government initiatives, and research and development efforts focused on improving diagnosis, treatment, and quality of life for individuals with cerebral palsy.
Data Bridge Market Research analyses that the global cerebral palsy market which was USD 2,618.74 million in 2022, is expected to reach USD 6,548.64 million by 2030, and is expected to undergo a CAGR of 6.20% during the forecast period of 2023 to 2030. “Ataxia Cerebral Palsy” dominates the type segment of the global cerebral palsy market owing to the high prevalence of this type of cerebral palsy. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cerebral Palsy Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Ataxia Cerebral Palsy, Athetoid Cerebral Palsy, Congenital Cerebral Palsy, Diplegia of Cerebral Palsy, Hemiparesis of Cerebral Palsy, Postnatal Cerebral Palsy, Spastic Cerebral Palsy and Others), Diagnosis (Imaging Tests, Laboratory Tests and Others), Treatment (Therapy, Medication and Surgery), Medical Devices (Orthotic Devices, ENT-Devices and Eye-Tracking Devices), Mobility Aids (Walkers, Walking Sticks and Canes, Crutches, Standers, Lifts, Wheelchairs, Power Scooters and Others), End User (Hospitals, Home Care, Physiotherapy Centres, Pathology Centres, Ambulatory, Speciality Clinics and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Abbott (U.S.), Medtronic (Ireland), Allergan (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson Private Limited (U.S.), Pfizer Inc. (U.S.), Novartis International AG (Switzerland), GSK plc. (U.K.), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), Ipsen (France), Acorda Therapeutics, Inc. (U.S.), Merck KGaA (Germany)
|
|
Market Opportunities
|
|
Market Definition
Cerebral palsy is a neurological disorder that directly and adversely has an impact on individuals body balance, body posture and body motion. Cerebral palsy is a common childhood incapacity wherein there are unconscious movements, rigidity or floppiness of the limbs and trunk, unstable walking and abnormal reflexes.
Global Cerebral Palsy Market Dynamics
Drivers
- The Upsurge in the Prevalence of Cerebral Palsy globally
Surging prevalence of cerebral palsy all around the globe is one of the major factors responsible for fostering growth in the market value. Growing number of different types of cerebral palsy, rising awareness about the diseases are all responsible for boosting the market growth rate.
- Research and Development Proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the pharmaceutical drugs and various diagnosis methods will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the integration of advanced technologies in the healthcare facilities is also bolstering the market growth rate.
- Growing Investment for Healthcare Facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
- Expansion of the Pharmaceutical Industry
The pharmaceuticals industry is experiencing growth due to various factors, including advancements in device development, increasing investments in research and development, and expanding healthcare infrastructure. This growth directly impacts the global cerebral palsy market.
-
Government Investments on Healthcare Infrastructure
The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Also, high return on investments assured by the research activities will also work in the favor of the market.
Restraints/Challenges
- Rising Competition
The global cerebral palsy market is highly competitive, with numerous companies offering a wide range of products. This can make it challenging for new entrants or smaller companies to gain market share and establish a strong presence.
-
High Cost associated with Drug Development and Distribution
The cost of drug development and its distribution is very high in the market. Healthcare systems and payers face cost pressures, and there is a growing demand for cost-effective solutions. Manufacturers need to balance the development of innovative implants with affordability to meet market demands.
This global cerebral palsy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global cerebral palsy Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2021, Medtronic announced the launch of the InterStim Micro neurostimulator, a device used for sacral neuromodulation therapy, which has shown potential benefits for patients with chronic bowel control problems, including those with cerebral palsy
- In June 2021, Allergan has been involved in clinical trials investigating the use of botulinum toxin type A (BOTOX) for the treatment of spasticity in children with cerebral palsy. These studies aim to evaluate the safety and efficacy of BOTOX® in reducing muscle stiffness and improving functional outcomes
Global Cerebral Palsy Market Scope
The global cerebral palsy market is segmented on the basis of type, diagnosis, treatment, medical devices, mobility aids and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Ataxia Cerebral Palsy
- Athetoid Cerebral Palsy
- Congenital Cerebral Palsy
- Diplegia of Cerebral Palsy
- Hemiparesis of Cerebral Palsy
- Postnatal Cerebral Palsy
- Spastic Cerebral Palsy
- Others
Diagnosis
- Imaging Tests
- Magnetic Resonance Imaging (MRI)
- Cranial Ultrasound
- Computerized Tomography (CT)
- Electroencephalogram (EEG)
- Laboratory Tests
- Blood Test
- Urine Test
- Skin Test
- Genetic/ Metabolic Test
- Others
- Others
Treatment
- Medication
- Anti-Convulsant Drugs
- Muscle Relaxants Drugs
- Anti-Depressants Drugs
- Anti-Spastic Drugs
- Anti-Inflammatory Drugs
- Others
- Therapy
- Nutrition Therapy
- Hyperbaric Oxygen Therapy
- Occupational Therapy
- Physical Therapy
- Stem Cell Therapy
- Others
- Surgery
- Orthopaedic Surgery
- Selective Dorsal Rhizotomy Surgery
- Others
Medical Devices
- Orthotic Devices
- Foot Orthotics
- Ankle-Foot Orthotics
- Knee-Ankle Orthotics
- Spinal Orthotics
- Prophylactic Braces
- Others
- ENT-Devices
- Electronic Communication Boards
- Hearing Aid And Implants
- Eye-Tracking Devices
Mobility Aids
- Walkers
- Walking Sticks And Canes
- Crutches
- Standers
- Lifts
- Wheelchairs
- Power Scooters
- Others
End User
- Hospitals
- Home Care
- Physiotherapy Centres
- Pathology Centres
- Ambulatory
- Speciality Clinics
- Others
Global Cerebral Palsy Market Regional Analysis/Insights
The global cerebral palsy market is analysed and market size insights and trends are provided by country, type, diagnosis, treatment, medical devices, mobility aids and end user as referenced above.
The countries covered in the global cerebral palsy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global cerebral palsy market because of the strong base of healthcare facilities, strong presence of major players in the market, and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth in the global cerebral palsy market during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global cerebral palsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global cerebral palsy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global cerebral palsy market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Cerebral Palsy Market Share Analysis
The global cerebral palsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global cerebral palsy market.
Some of the major players operating in the global cerebral palsy market are:
- Abbott (U.S.)
- Medtronic (Ireland)
- Allergan (Ireland)
- Boston Scientific Corporation (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Pfizer Inc. (U.S.)
- Novartis International AG (Switzerland)
- GSK plc (U.K.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bayer AG (Germany)
- Ipsen (France)
- Acorda Therapeutics, Inc. (U.S.)
- Merck KGaA (Germany)
SKU-